Insulet | PODD - 债务



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 10.3B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


债务 更改 日
Abbott USD 34.05B 20.19B 2026-03
Align Technology USD 116.04M 1.6M 2026-03
AtriCure USD 71.78M 1.6M 2026-03
Baxter International USD 9.69B 93M 2026-03
Becton, Dickinson and Co. USD 17.28B 2.26B 2026-03
Boston Scientific USD 11.03B 407M 2026-03
Cardinal Health USD 8.89B 30M 2026-06
Cooper Companies USD 2.5B 5.6M 2025-12
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Globus Medical USD 115.22M 3.43M 2026-03
ICU Medical USD 1.23B 94.6M 2026-06
Inogen USD 0 0 2022-06
Insulet USD 948.4M 300K 2026-06
Integra LifeSciences USD 2.04B 6.27M 2026-03
J&J USD 54.99B 7.05B 2026-03
Medtronic USD 27.96B 110M 2026-03
Merit Medical Systems USD 821.56M 9K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 132.16M 2026-06
Teleflex USD 2.69B 39.95M 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03
Zimmer Biomet Holdings USD 7.48B 8M 2026-06